2018
Monoamine Transporter and Receptor Interaction Profiles in Vitro Predict Reported Human Doses of Novel Psychoactive Stimulants and Psychedelics
Abstract: BackgroundPharmacological profiles of new psychoactive substances can be established rapidly in vitro and provide information on potential psychoactive effects in humans. The present study investigated whether specific in vitro monoamine transporter and receptor interactions can predict effective psychoactive doses in humans.MethodsWe correlated previously assessed in vitro data of stimulants and psychedelics with human doses that are reported on the Internet and in books.ResultsFor stimulants, dopamine and no…
Search citation statements
Paper Sections
Select...
45
15
11
3
Citation Types
2
58
0
0
Year Published
2018
2026
Publication Types
Select...
58
6
2
2
Relationship
8
60
Authors
Journals
Cited by 64 publications
(60 citation statements)
References 48 publications
2
58
0
0
“…The rank order of affinity observed in our study for all the 2C-O and amphetamine-based derivatives at TAAR1 (rat > mouse > human TAAR1) was consistent with previous studies that investigated substituted phenethylamines with various bulky modifications (Lewin et al, 2008; Luethi et al, 2018; Luethi et al, 2019).…”
Section: Discussionsupporting
confidence: 92%
“…The rank order of affinity observed in our study for all the 2C-O and amphetamine-based derivatives at TAAR1 (rat > mouse > human TAAR1) was consistent with previous studies that investigated substituted phenethylamines with various bulky modifications (Lewin et al, 2008; Luethi et al, 2018; Luethi et al, 2019).…”
Section: Discussionsupporting
confidence: 92%
“…In the current study, methylone was a potent inhibitor of norepinephrine uptake and to a lesser extent an inhibitor of dopamine and 5-HT uptake. The N -demethylated metabolite MDC exerted similar 5-HT uptake inhibition potency to methylone but much weaker potency at norepinephrine and dopamine uptake inhibition, suggesting weaker psychotropic effects compared to the parent compound (Luethi and Liechti, 2018), which is in accordance with animal studies (Elmore et al, 2017). The partial dopamine inhibition by HHMC at sub-micromolar concentrations may not be sufficient to produce discernable dopaminergic effects over the course of time after methylone intake.…”
Section: Discussionsupporting
confidence: 81%
“…Studies investigating the association of 5-HT 1A receptor activation and immune modulation showed that the potent and selective 5-HT 1A receptor agonist DPAT induces lymphocyte proliferation probably by increased translocation of NF-κB into the nucleus (20, 21). However, none of these studies observed immunomodulatory effects of psychedelics, although several psychedelics potently activate the 5-HT 1A receptor (48). We, therefore, assume that the in the current study tested psychedelics are, in contrast to DPAT, not potent or selective enough 5-HT 1A receptor agonists to induce immune modulation.…”
Section: Discussionmentioning
confidence: 73%

